< Back to all Breaking News
BIVI
10/22/2019 08:10am
BioVie submits protocol for Phase 2b/3 refractory ascites study to FDA 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
